Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 4 Open-market sale General Counsel sold 1,897 shares at $8.90 ($16,893)
  2. 4 Open-market sale Chief Financial Officer sold 1,336 shares at $8.90 ($11,897)
  3. 4 Open-market sale Chief Scientific Officer sold 1,602 shares at $8.90 ($14,266)
  4. 4 Open-market sale CMO sold 3,254 shares at $8.90 ($28,977)
  5. 4 Open-market sale President and CEO sold 3,203 shares at $8.90 ($28,522)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale General Counsel sold 4,730 shares at $9.76 ($46,155)
  11. 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
  12. 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
  13. 4 Open-market buy 10% owner bought 484,496 shares at $10.32 ($4,999,999)
  14. 4 Open-market sale General Counsel sold 4,730 shares at an average $10.91 ($51,598)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 11 · 203 filings